ICON Public Limited Company

ICLR · Healthcare · Diagnostics & Research · Valued as of 2026-11-03 · Statements 2025-12-31

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

What it is worth

EPV + Growth

6.74B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

6.84B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

7.13B USD

15 years of cash for shareholders and lenders, less what is owed

Average Intrinsic Value

6.90B USD

The plain average of EPV, Profit and FCFF

Against the price

Market Cap

12.50B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.55×

the ratio the screener ranks by

Margin of Safety

-81.1%

1 − Market Cap / Average Intrinsic Value

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

Earnings power value plus growth: 6.74B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)9.31B USD
−②Net Debt Today2.57B USD
+③Growth Value0 USD
=Value6.74B USD

EPV of the Operations (NOPAT over WACC)

9.31B USD

Net debt today

-2.57B USD

Growth Value

0 USD

Value

6.74B USD

①EPV (Earnings Power Value)

9.31B USD

②Net Debt Today

2.57B USD

③Growth Value

0 USD

Market value

Market Cap12.50B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-85.5%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 6.84B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE4.34B USD
+②Equity at Year 15, Today2.50B USD
=Value6.84B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

4.34B USD

②Equity at Year 15, Today

2.50B USD

Market value

Market Cap12.50B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-82.7%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 7.13B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF6.87B USD
+②Invested Capital at Year 15, Today2.82B USD
−③Net Debt Today2.57B USD
=Value7.13B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment rising to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

6.87B USD

②Invested Capital at Year 15, Today

2.82B USD

③Net Debt Today

2.57B USD

Market value

Market Cap12.50B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-75.4%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 10.22%
Cost of Equity =Risk-Free Rate 4.50%+Beta 1.20×Market Risk Premium 6.00%= 11.71%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 23.15M USDPretax Income 252.72M USD= 9.16%

The tax the interest saves.

Interest Expense =EBIT 441.01M USD−Pretax Income 252.72M USD= 188.30M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 188.30M USDTotal Debt 3.50B USD×(1 − Tax Rate for WACC 9.16%)= 4.89%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 3.50B USDMarket Cap + Total Debt 12.50B USD + 3.50B USD= 21.86%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 78.14%×Cost of Equity 11.71%+Debt Weight 21.86%×Cost of Debt 4.89%= 10.22%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 16.42B USD − Total Liabilities 7.03B USD = Book Value Today 9.39B USD

Total Debt 3.50B USD − Cash and Short-Term Investments 929.31M USD = Net Debt Today 2.57B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-6.5%at most 5%passes77,154,209 / 82,495,086
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets4.9%at least -10.0%passes(1.04B USD − 229.57M USD) ÷ 16.42B USD
Price to bookMarket Cap ÷ Book Value Today1.33×at most 3×passes12.50B USD ÷ 9.39B USD
Operating marginOperating Income ÷ Revenue12.3%above 10.0%passes1.01B USD ÷ 8.26B USD
Revenue growthRevenue ÷ Revenue a Year Before − 10.8%above 10.0%does not pass8.26B USD / 8.20B USD
Net cash(Cash − Total Debt) ÷ Market Cap-20.5%above -30%passes(929.31M USD − 3.50B USD) ÷ 12.50B USD
Operating efficiencyOperating Income ÷ Gross Profit46.5%above 25.0%passes1.01B USD ÷ 2.18B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

162.01 USD

Enterprise value

15.10B USD

the provider's own figure

EV / EBITDA

28.82×

Price / book

1.33×

the provider's book

Price / earnings

249.00×

Return on equity

0.3%

the provider's figure, not this page's

Profit margin

0.3%

Revenue growth

1.2%

Analyst target, mean

186.95 USD

Analysts

17

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

Income statement (USD)2022202320242025

Revenue

7.75B8.06B8.20B8.26B

Gross profit

2.22B2.35B2.37B2.18B

Operating income

866.94M995.22M1.16B1.01B

EBITDA

operating income before depreciation and amortisation

1.35B1.47B1.50B824.39M

Pretax income

568.42M573.55M804.56M252.72M

Net income

505.81M554.76M739.87M229.57M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

569.30M641.54M851.89M747.29M

R&D

————
Balance sheet, year end (USD)2022202320242025

Total assets

17.20B16.88B16.65B16.29B

Total liabilities

8.70B7.66B7.20B7.08B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

8.51B9.22B9.45B9.20B

Total debt

4.83B3.94B3.61B3.56B

Cash and equivalents

289.06M378.48M539.32M647.94M

Net PP&E

fixed assets after depreciation

504.66M502.02M531.01M525.20M

Working capital

current assets less current liabilities

539.00M557.44M640.32M305.81M
Cash flow (USD)2022202320242025

Operating cash flow

563.88M1.16B1.29B1.04B

Capital expenditure

paid out, so below zero

-142.30M-140.83M-168.23M-174.39M

Depreciation and amortisation

570.08M586.54M488.99M383.38M

Free cash flow

operating cash flow plus capital expenditure

421.58M1.02B1.12B862.85M